secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001140361-26-013070
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata extends tender offer deadline to April 13, 2026 per waiver
-----------------------------------------------------------------

- Deadline to commence tender offer moved from April 3 to April 13, 2026.
- Waiver signed April 2 by Lisata, Kuva Labs Inc., and Kuva Acquisition Corp.
- All other Merger Agreement terms (March 6, 2026) remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000114036126013070/0001140361-26-013070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000114036126013070/ef20069819_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-013070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer